In addition, using Neuro2A cells (neuroblastoma cell line) and a DOCA-salt model of hypertension, the antioxidant therapy preserved ACE2 compensatory role by breaking the feedforward cycle between oxidative stress and ADAM17 especially due to the oxidative stress decreasing. Here, ACE2 is linked to hypertensive disorder.